S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Curative Biotechnology Stock Forecast, Price & News

-0.01 (-9.09%)
(As of 11/26/2021 12:58 PM ET)
Today's Range
50-Day Range
52-Week Range
252,386 shs
Average Volume
1.55 million shs
Market Capitalization
$38.12 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive CUBT News and Ratings via Email

Sign-up to receive the latest news and ratings for Curative Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

About Curative Biotechnology

Curative Biotechnology, Inc. engages in the provision of software solutions for the healthcare market. Its products include MedFlash, electronic Personal Health Manager, Medical Alert, personal emergency response services, product and medical transcription, disease management, revenue cycle management, and medical consulting-billing. The company was founded by Jon Pevzner on July 29, 1995 and is headquartered in Boca Raton, FL.


See More Headlines

Industry, Sector and Symbol

Miscellaneous health & allied services, not elsewhere classified
Current Symbol
Year Founded

Sales & Book Value

Annual Sales


Pretax Margin




Free Float
Market Cap
$38.12 million
Not Optionable

Company Calendar

Fiscal Year End


Overall MarketRank

0.00 out of 5 stars

Medical Sector

1387th out of 1,391 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

21st out of 21 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Curative Biotechnology (NASDAQ:CUBT) Frequently Asked Questions

Who are Curative Biotechnology's key executives?

Curative Biotechnology's management team includes the following people:
  • Paul M. Michael, Executive Chairman & President
  • I. Richard Garr, Chief Executive Officer & General Counsel
  • Ron Bordens, Executive VP-Technical Operations & Manufacturing
  • Barry A. Ginsberg, Vice Chairman & Chief Strategy Officer

What is Curative Biotechnology's stock symbol?

Curative Biotechnology trades on the NASDAQ under the ticker symbol "CUBT."

How do I buy shares of Curative Biotechnology?

Shares of CUBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Curative Biotechnology's stock price today?

One share of CUBT stock can currently be purchased for approximately $0.07.

How much money does Curative Biotechnology make?

Curative Biotechnology has a market capitalization of $38.12 million.

What is Curative Biotechnology's official website?

The official website for Curative Biotechnology is curativebiotech.com.

Where are Curative Biotechnology's headquarters?

Curative Biotechnology is headquartered at 49 SW Flagler Avenue Suite 302, Stuart FL, 34994.

How can I contact Curative Biotechnology?

Curative Biotechnology's mailing address is 49 SW Flagler Avenue Suite 302, Stuart FL, 34994. The company can be reached via phone at (561) 418-7725, via email at [email protected], or via fax at 866-900-1002.

This page was last updated on 11/28/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.